Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IofinaIOFNF 71 3-Year Revenue Growth Rate is 12.60% as of Dec. 2025, which is 2% below its 10-year median of 12.80. GuruFocus rates IOFNF with a GF Score™ of 71/100 and a GF Value™ of $0.40 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 1,538 Chemicals companies, Iofina ranks better than 86.28% on this metric.
During the past 12 months, Iofina's average Revenue per Share Growth Rate was 15.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 12.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 16.10% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 10.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Iofina was 41.30% per year. The lowest was -14.90% per year. And the median was 12.80% per year.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
Iofina 3-Year Revenue Growth Rate Related Terms
IOFNF vs LIN, SHW, ECL: 3-Year Revenue Growth Rate Comparison
For the Specialty Chemicals subindustry, Iofina's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Iofina 3-Year Revenue Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Iofina's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where Iofina's 3-Year Revenue Growth Rate falls into.
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
What does a 3-Year Revenue Growth Rate of 12.60% mean?
Iofina (IOFNF) has a 3-Year Revenue Growth Rate of 12.60% as of Dec. 2025. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for Iofina and its competitors. This is near median its historical median of 12.80. According to the industry distribution chart, Iofina ranks #211 out of 1538 companies in the Chemicals industry, placing it in the top 13.7%.
Is Iofina's 3-Year Revenue Growth Rate too high?
Iofina's current 3-Year Revenue Growth Rate of 12.60% is near median its 10-year median of 12.80. Based on the distribution chart, Iofina ranks #211 out of 1538 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Iofina has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Iofina's 3-Year Revenue Growth Rate compare to LIN and SHW?
According to the Chemicals industry distribution chart, Iofina ranks #211 out of 1538 companies for 3-Year Revenue Growth Rate. This places Iofina in the top 14% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Revenue Growth Rate for a Chemicals company?
A good 3-Year Revenue Growth Rate depends on the Chemicals industry context. However, 3-Year Revenue Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Revenue Growth Rate mean?
A high 3-Year Revenue Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for Iofina and its competitors. Iofina's current 3-Year Revenue Growth Rate is 12.60%, which is near median its own 10-year median of 12.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Iofina stock overvalued right now?
Based on GuruFocus' analysis, Iofina (IOFNF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.40, compared to a current price of $0.74 — trading 86.2% above its estimated fair value. The current 3-Year Revenue Growth Rate is 12.60%, which is near median its 10-year median of 12.80. Iofina's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Revenue Growth Rate calculated?
3-Year Revenue Growth Rate is calculated from a company's financial statements. For Iofina (IOFNF), the current 3-Year Revenue Growth Rate is 12.60% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Iofina (IOFNF) Overvalued in 2026?
Based on GuruFocus' analysis, Iofina stock appears to be overvalued.
The current stock price of $0.74 is trading 86.2% above its estimated GF Value™ of $0.40.
GuruFocus considers Iofina to be Significantly Overvalued.
Key valuation signals for IOFNF:
3-Year Revenue Growth Rate: 12.60% (near median its 10-year median of 12.80)
GF Value™: $0.40 vs. price of $0.74 (86.2% above fair value)
No single metric tells the full story. See the IOFNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Iofina PLC is a holding company engaged in the exploration and isolation of iodine and the production of specialty chemicals. The company's operating segment includes Halogen Derivatives & Iodine and Hemp seeds. Its geographical segments include the United States of America and the United Kingdom and it derives a majority of its revenue from the North America.
71GF Score
Get the complete analysis for IOFNF
3-Year Revenue Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IOFNF has been successfully added to your 
